Charles Greg Guyer - 31 Dec 2025 Form 5 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
31 Dec 2025
Net transactions value
+$19,985
Form type
5
Filing time
13 Feb 2026, 18:56:35 UTC
Previous filing
18 Mar 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guyer Charles Greg EVP, Chief Technical Officer C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL /s/ Tae Sang Yoo, Attorney-in-Fact 13 Feb 2026 0001811096

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $17,161 +317 +0.39% $54.14 81,155 30 Apr 2025 Direct F1
transaction BMRN Common Stock Award $2,823 +62 +0.08% $45.54 81,217 31 Oct 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan.